Monte Rosa Therapeutics, Inc.GLUE

3 13D/G filings 2 distinct filers 0 insider transactions (365d)

Post-Filing Returns · across 3 activist filings on this issuer

Median 30d

0.0%

avg 0.0%

Median 60d

0.0%

avg 0.0%

Median 90d

0.0%

avg 0.0%

Median 180d

0.0%

avg 0.0%

Returns measured from each activist filing's date_of_event, split + dividend adjusted via Yahoo Finance.

Activist filings

1 SCHEDULE 13D/A · 2 SCHEDULE

Distinct filers

multi-activist cluster

Insiders (365d)

0 buys · 0 sales

Latest short DTC

16.56

as of 2026-08-31

Held by elite portfolio managers

1 holder · $7K

Duquesne Family Office

Filed	Form	Filer	Stake	Shares
2026-07-06	SCHEDULE 13D/A	New Enterprise Associates 17, L.P.	—	6,692,298	view →
2026-01-09	SCHEDULE	Versant Venture Capital VI, L.P.	3.40%	2,236,708	view →
2025-11-12	SCHEDULE	Versant Venture Capital VI, L.P.	5.10%	3,334,669	view →

Settlement	Short Interest	Days to Cover	% Δ vs prior
2026-08-31	18,075,786	16.56	+3.5%
2026-08-14	17,457,317	13.99	+6.1%
2026-07-31	16,458,543	10.59	-4.3%
2026-07-15	17,195,471	13.08	-7.7%
2026-06-30	18,634,735	8.49	+8.5%
2026-06-15	17,170,729	16.62	+7.3%
2026-05-29	16,005,122	19.21	+7.0%
2026-05-15	14,962,299	20.63	-1.2%
2026-04-30	15,142,638	17.85	-4.4%
2026-04-15	15,837,633	15.99	+18.2%
2026-03-31	13,398,925	8.81	+22.2%
2026-03-13	10,964,393	12.64	+8.4%

Free. We email you when criteria match. One-click unsubscribe in every email.

Custom alerts · full feed · daily intelligence · API. From $49/mo.